Form 990-EZ for tax year 2023
Filed by NATIONAL NETWORK OF ABORTION FUNDS.
Totals
- Total revenue
- $103,703
- Total expenses
- $84,693
- Contributions and grants received
- $94,452
- Grants paid
- $80,751
- Program service revenue
- $0
- Membership dues (line 3)
- $0
- Investment income (line 4)
- $9,251
- Gain or loss on sale of assets (line 5c)
- $0
- Gaming and fundraising events, net (line 6d)
- $0
- Gross profit on inventory sales (line 7c)
- $0
- Other revenue (line 8)
- $0
- Total assets, end of year
- $239,867
- Total liabilities, end of year
- not reported
- Net assets or fund balances, end of year
- $239,867
- Program service expenses (Part III)
- $44,201
Program services were 52.2% of total expenses calculated — Part III's total program service expenses over total expenses, both as filed.
Mission and programs · 2023
Primary exempt purpose
FUNDING HEALTHCARE AND SUPPORT SERVICES FOR PATIENTS SEEKING ABORTIONS
-
OUR JUSTICE - MN
Expenses $10,000
-
PLANNED PARENTHOOD OF WI
Expenses $17,201
-
PLANNED PARENTHOOD OF IL
Expenses $10,000
-
AFFILIATED MEDICAL SERVICES
Expenses $7,000
As filed on the 2023 return.
Listed in Part IV
-
Brenda McClellan-TilsonBRENDA MCCLELLAN-TILSON
TREASURER
- Total calculated
- $0
- Hours/week
- 15
-
Christina RensCHRISTINA RENS
PRESIDENT
- Total calculated
- $0
- Hours/week
- 20
Compensation is as filed in Part IV of the Form 990-EZ: compensation, contributions to benefit plans, expense account, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total.
Grants on this return
No itemized grants to organizations on this return.
Provenance
- Return type
- form_990_ez
- Tax year
- 2023
- Filed
- 11 October 2024
- IRS schema version
- 2023v5.0
- Source object
- 202402859349201120
Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.
The source document this was parsed from is served over the API, which is where bulk and document access live.